مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,336
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ARMS-PCR VERSUS AS-PCR TO EVALUATE JAK2V617F MUTATION IN PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS

Pages

  207-211

Abstract

 Background: JAK2 is a nonreceptor tyrosine kinase that plays a major role in myeloid disorders. This MUTATION is characterized by a G to T transverse at nucleotide 1849 in exon 12 of the JAK2 gene, located on the chromosome 9p, leading to a substitution of valine to phenylalanine at amino acid position 617 in the JAK2 protein. In this study we compared the amplification refractory MUTATION (ARMS) assay and allele- specific (ASPCR) to evaluate JAK2V617F MUTATION patients with non-CML MYELOPROLIFERATIVE NEOPLASMs (MPNS).Methods: In this experimental study we evaluated JAK2 MUTATION in 58 patients with a known or suspected diagnosis of a MYELOPROLIFERATIVE NEOPLASM by simple randomized sampling. The MUTATION was detected by ARMS-PCR and AS-PCR in patients. In order to verify the methods, amplified products from some patients were sequenced.Results: The JAK2 V617F MUTATION was detected in 86.6% (26/30) of patients with polycythemia vera and 61.5% (8/13) of patients with idiopathic myelofibrosis by ARMSPCR and AS-PCR.46.6% (7.15) of essential thrombocythemia patients were positive using ARMS- PCR method while 53% (8.15) of then were positive when AS- PCR were used. The MUTATION was confirmed by sequencing.Conclusions: The incidence of JAK2 MUTATION using above PCR methods is similar to previous studies. The different results may depend on the molecular technique used.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    NADALI, FATEMEH, FERDOWSI, SHIRIN, KARIMZADEH, PARISA, CHAHARDOULI, BAHRAM, EINOLLAHI, NAHID, MOUSAVI, ASADOLLAH, BAHAR, BABAK, DARGAHI, HOSEIN, TOOGEH, GHOLAMREZA, ALIMOGHADDAM, KAMRAN, GHAVAMZADEH, ARDESHIR, & GHAFFARI, SEYED HAMID. (2010). ARMS-PCR VERSUS AS-PCR TO EVALUATE JAK2V617F MUTATION IN PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 68(4), 207-211. SID. https://sid.ir/paper/38097/en

    Vancouver: Copy

    NADALI FATEMEH, FERDOWSI SHIRIN, KARIMZADEH PARISA, CHAHARDOULI BAHRAM, EINOLLAHI NAHID, MOUSAVI ASADOLLAH, BAHAR BABAK, DARGAHI HOSEIN, TOOGEH GHOLAMREZA, ALIMOGHADDAM KAMRAN, GHAVAMZADEH ARDESHIR, GHAFFARI SEYED HAMID. ARMS-PCR VERSUS AS-PCR TO EVALUATE JAK2V617F MUTATION IN PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2010;68(4):207-211. Available from: https://sid.ir/paper/38097/en

    IEEE: Copy

    FATEMEH NADALI, SHIRIN FERDOWSI, PARISA KARIMZADEH, BAHRAM CHAHARDOULI, NAHID EINOLLAHI, ASADOLLAH MOUSAVI, BABAK BAHAR, HOSEIN DARGAHI, GHOLAMREZA TOOGEH, KAMRAN ALIMOGHADDAM, ARDESHIR GHAVAMZADEH, and SEYED HAMID GHAFFARI, “ARMS-PCR VERSUS AS-PCR TO EVALUATE JAK2V617F MUTATION IN PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 68, no. 4, pp. 207–211, 2010, [Online]. Available: https://sid.ir/paper/38097/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top